The European Commission is continuing discussions with the pharmaceutical industry to ensure rapid, safe and affordable access to future Covid-19 vaccines, said the Deputy Director General of DG Trade, Sandra Gallina, who is in charge of these negotiations. She was answering questions from MEPs on the Committee on Public Health who were very concerned that they were not more involved in the process.
Discussions again revolved around the obligations of the pharmaceutical industry. Sandra...